121 related articles for article (PubMed ID: 12623055)
1. Inactivated rabies vaccine control and release: use of an ELISA method.
Fournier-Caruana J; Poirier B; Haond G; Jallet C; Fuchs F; Tordo N; Perrin P
Biologicals; 2003 Mar; 31(1):9-16. PubMed ID: 12623055
[TBL] [Abstract][Full Text] [Related]
2. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
4. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
[TBL] [Abstract][Full Text] [Related]
5. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
[TBL] [Abstract][Full Text] [Related]
6. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
7. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
8. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
Liu Y; Zhang S; Zhang F; Hu R
Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a real-time RT-PCR assay for the quantification of rabies virus as quality control of inactivated rabies vaccines.
Lourenç Correia Moreira B; Aparecida Pereira L; Lappas Gimenez AP; Minor Fernandes Inagaki J; Raboni SM
J Virol Methods; 2019 Aug; 270():46-51. PubMed ID: 31047970
[TBL] [Abstract][Full Text] [Related]
10. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody.
Perrin P; Morgeaux S; Sureau P
Biologicals; 1990 Oct; 18(4):321-30. PubMed ID: 2285504
[TBL] [Abstract][Full Text] [Related]
11. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
[TBL] [Abstract][Full Text] [Related]
12. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
[TBL] [Abstract][Full Text] [Related]
13. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
Daas A; Milne C
Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282
[TBL] [Abstract][Full Text] [Related]
14. Development of a relative potency test using ELISA for human rabies vaccines.
Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
[TBL] [Abstract][Full Text] [Related]
15. A novel in vitro ELISA for estimation of glycoprotein content in human rabies vaccines.
Aavula SM; Abhinay G; Nimmagadda SV; Maithal K
J Immunoassay Immunochem; 2017; 38(4):400-410. PubMed ID: 28436708
[TBL] [Abstract][Full Text] [Related]
16. [Potency testing of inactivated rabies vaccines. Problems posed by the use of the Habel test].
Aubert MF; Andral L
Comp Immunol Microbiol Infect Dis; 1979; 1(4):341-9. PubMed ID: 318239
[TBL] [Abstract][Full Text] [Related]
17. Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection.
Moreira BLC; Gimenez APL; Inagaki JMF; Raboni SM
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008142. PubMed ID: 32210437
[TBL] [Abstract][Full Text] [Related]
18. Use of ELISA for in vitro potency test of rabies vaccines for animal use.
Gamoh K; Senda M; Itoh O; Muramatsu M; Hirayama N; Koike R; Endoh YS; Minamoto N
Biologicals; 1996 Jun; 24(2):95-101. PubMed ID: 8889055
[TBL] [Abstract][Full Text] [Related]
19. Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
Morgeaux S; Poirier B; Ragan CI; Wilkinson D; Arabin U; Guinet-Morlot F; Levis R; Meyer H; Riou P; Shaid S; Volokhov D; Tordo N; Chapsal JM
Vaccine; 2017 Feb; 35(6):966-971. PubMed ID: 28081969
[TBL] [Abstract][Full Text] [Related]
20. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
Daas A; Bruckner L; Milne C
Pharmeur Bio Sci Notes; 2015; 2015():57-72. PubMed ID: 26830159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
